Department of Chemistry, The University of Texas at Austin, Austin, Texas 78712, United States.
Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712, United States.
ACS Infect Dis. 2024 Oct 11;10(10):3597-3606. doi: 10.1021/acsinfecdis.4c00444. Epub 2024 Sep 20.
Here we used native mass spectrometry (native MS) to probe a SARS-CoV protease, PLpro, which plays critical roles in coronavirus disease by affecting viral protein production and antagonizing host antiviral responses. Ultraviolet photodissociation (UVPD) and variable temperature electrospray ionization (vT ESI) were used to localize binding sites of PLpro inhibitors and revealed the stabilizing effects of inhibitors on protein tertiary structure. We compared PLpro from SARS-CoV-1 and SARS-CoV-2 in terms of inhibitor and ISG15 interactions to discern possible differences in protease function. A PLpro mutant lacking a single cysteine was used to localize inhibitor binding, and thermodynamic measurements revealed that inhibitor PR-619 stabilized the folded PLpro structure. These results will inform further development of PLpro as a therapeutic target against SARS-CoV-2 and other emerging coronaviruses.
在这里,我们使用天然质谱(native MS)来探测 SARS-CoV 蛋白酶 PLpro,该酶通过影响病毒蛋白的产生和拮抗宿主抗病毒反应,在冠状病毒病中发挥关键作用。我们使用紫外线光解(UVPD)和可变温度电喷雾电离(vT ESI)来定位 PLpro 抑制剂的结合位点,并揭示了抑制剂对蛋白质三级结构的稳定作用。我们比较了 SARS-CoV-1 和 SARS-CoV-2 的 PLpro 抑制剂和 ISG15 相互作用,以辨别蛋白酶功能的可能差异。我们使用缺乏单个半胱氨酸的 PLpro 突变体来定位抑制剂结合,热力学测量表明抑制剂 PR-619 稳定了折叠的 PLpro 结构。这些结果将为进一步开发 PLpro 作为针对 SARS-CoV-2 和其他新兴冠状病毒的治疗靶标提供信息。